{
    "root": "7e5ae919-bb2d-4b73-9c2d-0fe1a367c17e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Brimonidine tartrate",
    "value": "20250321",
    "ingredients": [
        {
            "name": "BRIMONIDINE TARTRATE",
            "code": "4S9CL2DY2H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_51157"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED",
            "code": "K679OBS311",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_85146"
        },
        {
            "name": "SODIUM BORATE",
            "code": "91MBZ8H3QO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_22908"
        },
        {
            "name": "BORIC ACID",
            "code": "R57ZHV85D4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_33118"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "POTASSIUM CHLORIDE",
            "code": "660YQ98I10",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32588"
        },
        {
            "name": "CALCIUM CHLORIDE",
            "code": "M4I0D6VV5M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17996"
        },
        {
            "name": "MAGNESIUM CHLORIDE",
            "code": "02F3473H9O",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17996"
        },
        {
            "name": "SODIUM CHLORITE",
            "code": "G538EBV4VF",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_78667"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM",
            "code": "K679OBS311",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_85146"
        }
    ],
    "indications": {
        "text": "brimonidine tartrate ophthalmic solution 0.1 % 0.15 % indicated reduction elevated intraocular pressure ( iop ) patients open-angle glaucoma ocular hypertension .",
        "doid_entities": [
            {
                "text": "open-angle glaucoma (DOID:1067)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1067"
            },
            {
                "text": "glaucoma (DOID:1686)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1686"
            },
            {
                "text": "ocular hypertension (DOID:9282)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9282"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended one drop brimonidine tartrate ophthalmic solution 0.1 % 0.15 % affected eye ( ) three times daily , approximately 8 hours apart . brimonidine tartrate ophthalmic solution 0.1 % 0.15 % may used concomitantly topical ophthalmic products lower intraocular pressure . one topical ophthalmic product used , different products instilled least 5 minutes apart .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "brimonidine tartrate ophthalmic solution 0.1 % 0.15 % supplied sterile , teal opaque plastic ldpe bottles tips , purple high impact polystyrene ( hips ) caps follows : 0.1 % 5 ml 10 ml bottle ndc 82182-321-0510 ml 10 ml bottle ndc 82182-321-1015 ml 15 ml bottle ndc 82182-321-15 0.15 % 5 ml 10 ml bottle ndc 82182-773-0510 ml 10 ml bottle ndc 82182-773-1015 ml 15 ml bottle ndc 82182-773-15 storage : store 15oc 25oc ( 59of 77of ) .",
    "adverseReactions": "neonates infants ( pediatric patients younger 2 years old ) . ( 4.1 ) hypersensitivity . ( 4.2 )",
    "indications_original": "Brimonidine tartrate ophthalmic solution 0.1% or 0.15% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.",
    "contraindications_original": "The recommended dosage is one drop of brimonidine tartrate ophthalmic solution 0.1% or 0.15% in the affected eye(s) three times daily, approximately 8 hours apart. Brimonidine tartrate ophthalmic solution\u00a00.1% or 0.15% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure.\u00a0If more than one topical ophthalmic product is to be used, the different products should be instilled at least 5 minutes apart.",
    "warningsAndPrecautions_original": "Brimonidine tartrate ophthalmic solution 0.1% and 0.15% is supplied sterile, in teal opaque plastic LDPE bottles and tips, with purple high impact polystyrene (HIPS) caps as follows:\n                  \n                     0.1%\n                  \n                  5 mL in 10 mL bottle\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 82182-321-0510 mL in 10 mL bottle\n\t\t\u00a0\u00a0\u00a0\u00a0\u00a0\n\tNDC 82182-321-1015 mL in 15 mL bottle\n\t\t\u00a0\u00a0\u00a0\u00a0\u00a0\n\tNDC 82182-321-15\n                  \n                     0.15%\n                     5 mL in 10 mL bottle\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 82182-773-0510 mL in 10 mL bottle\n\t\t\u00a0\u00a0\u00a0\u00a0\u00a0\n\tNDC 82182-773-1015 mL in 15 mL bottle\n\t\t\u00a0\u00a0\u00a0\u00a0\u00a0\n\tNDC 82182-773-15 \n                  \n                     Storage: Store at 15oC to 25oC (59oF to 77oF).",
    "adverseReactions_original": "Neonates and infants  (pediatric patients younger than 2 years old).\u00a0( 4.1 ) Hypersensitivity Reactions. ( 4.2 )",
    "drug": [
        {
            "name": "Brimonidine tartrate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_51157"
        }
    ]
}